SCHEMBL7804654

SCHEMBL7804654

CN(C)CCNc1ccc2c3c(nn2CCNCCO)-c2ccncc2C(=O)c13

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 11/20 0.57
TP53 P04637 3/20 0.38
BLM P54132 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 2/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
TOP2B Q02880 1/20 0.37
ECE1 P42892 1/20 0.37
MUS81 Q96NY9 1/20 0.37
NSD2 O96028 2/20 0.34
FGB P02675 1/20 0.34
MMP14 P50281 1/20 0.34
MEN1 O00255 2/20 0.33
USP2 O75604 2/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
RECQL P46063 2/20 0.33
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Topixantrone SCHEMBL1344518 0.97 TOP2A (0.57) TOP2ATP53BLMSMN1; SMN2CYP3A4
Topixantrone SCHEMBL29371930 0.97 TOP2A (0.57) TOP2ATP53BLMSMN1; SMN2CYP3A4
Topixantrone SCHEMBL1418986 0.96 TOP2A (0.56) TOP2ATP53BLMSMN1; SMN2CYP3A4
Topixantrone SCHEMBL1230381 0.96 TOP2A (0.56) TOP2ATP53BLMSMN1; SMN2CYP3A4
SCHEMBL7810397 0.93 TOP2A (0.57) TOP2ATP53BLMSMN1; SMN2CYP3A4
SCHEMBL7804428 0.91 TOP2A (0.68) TOP2ATP53BLMSMN1; SMN2CYP3A4
SCHEMBL7804758 0.90 TOP2A (0.43) TOP2AECE1MUS81TDP1EHMT2
SCHEMBL7804772 0.90 TOP2A (0.57) TOP2ATP53BLMSMN1; SMN2CYP3A4
SCHEMBL7811993 0.90 TOP2A (0.61) TOP2ATP53BLMSMN1; SMN2CYP3A4
SCHEMBL7812036 0.89 TOP2A (0.43) TOP2AECE1MUS81TDP1EHMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP claimed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US claimed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO claimed
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed